Mitral bioprosthetic valve stenosis in a patient with antiphospholipid antibody syndrome and systemic lupus erythematosus

General Thoracic and Cardiovascular Surgery

Volumn 60, Issue 12, 2012, Pages 822-826

  Morisaki, Akimasa ^a   Hirai, Hidekazu ^a   Sasaki, Yasuyuki ^a   Hosono, Mitsuharu ^a   Sakaguchi, Masanori ^a   Nakahira, Atsushi ^a   Seo, Hiroyuki ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiphospholipid antibody syndrome; Structural valve deterioration; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; FIBRIN; HEPARIN; METHYLPREDNISOLONE; METICILLIN; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PROTHROMBIN; THROMBOPLASTIN; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN INFARCTION; CARDIOPULMONARY BYPASS; CASE REPORT; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUPUS ERYTHEMATOSUS NEPHRITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE THROMBOSIS; PROSTHETIC VALVE THROMBOSIS; REOPERATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ANTIPHOSPHOLIPID SYNDROME; BIOPROSTHESIS; CALCINOSIS; FEMALE; HEART FAILURE; HEART VALVE PROSTHESIS; HUMANS; MIDDLE AGED; MITRAL VALVE STENOSIS; PROSTHESIS FAILURE; REOPERATION;

EID: 84874504860     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-012-0091-6     Document Type: Article

References (13)

1. Colli A, Mestres CA, Espinosa G, Plasin MA, Pomar JL, Font J, et al. Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg. 2009;37:154-8.
2. Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2004;127:414-20. (Pubitemid 38176645)
3. Riess FC, Cramer E, Hansen L, Schiffelers S, Wahl G, Wallrath J, et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg. 2009;37:145-53.
4. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498-509.
5. Riess FC, Bader R, Cramer E, Hansen L, Kleijnen B, Wahl G, et al. Hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years. Ann Thorac Surg. 2007;83:1310-8. (Pubitemid 46440726)
6. Eichinger WB, Botzenhardt F, Gunzinger R, Kemkes BM, Sosnowski A, Maiza D, et al. European experience with the Mosaic bioprosthesis. J Thorac Cardiovasc Surg. 2002;124:333-9. (Pubitemid 35025610)
7. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg. 2003;126:965-8. (Pubitemid 37305676)
8. Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg. 2003;126:969-75. (Pubitemid 37305677)
9. Kato Y, Isobe F, Sasaki Y, Kumano H, Nagamachi K, Arimoto H. Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg. 2001;49:728-31.
10. Niaz A, Butany J. Antiphospholipid antibody syndrome with involvement of a bioprosthetic heart valve. Can J Cardiol. 1998;14:951-4. (Pubitemid 28395975)
11. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation. 1987;76:618-27. (Pubitemid 17124995)
12. Gorki H, Malinovski V, Stanbridge RD. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg. 2008;33:168-81.
13. Afek A, Shoenfeld Y, Manor R, Goldberg I, Ziporen L, George J, et al. Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus. 1999;8:502-7. (Pubitemid 29452561)